LAWRENCEVILLE, N.J.,
March 6, 2014 /PR Newswire/
-- Celsion Corporation (NASDAQ: CLSN) announced today that the
Company will host a conference call to discuss year-end 2013
financial results at 11:00 a.m. EST
on Thursday, March 13, 2014. To
participate in the call, interested parties may dial 1-888-572-7033
(Toll-Free/North America) or
1-719-325-2469 (International/Toll) and ask for the Celsion
Corporation 4th Quarter 2013 Conference Call (Conference
Code: 6632100) to register ten minutes before the call is scheduled
to begin. The call will also be broadcast live on the internet at
http://www.celsion.com.
The call will be archived for replay on Thursday, March 13, 2014 and will remain
available until Thursday, March 27,
2014. The replay can be accessed at 1-888-203-1112
(Toll-Free/North America) or
1-719-457-0820 (International/Toll) using Conference Code: 6632100.
An audio replay of the call will also be available on the Company's
website, http://www.celsion.com, for 30 days after 2:00 p.m. EST on Thursday,
March 13, 2014.
About Celsion Corporation
Celsion is dedicated to the development and commercialization of
innovative cancer drugs, including tumor-targeting treatments using
focused heat energy in combination with heat-activated liposomal
drug technology. Celsion has research, license or
commercialization agreements with leading institutions, including
the National Institutes of Health, Duke
University Medical Center, University
of Hong Kong, the University of Pisa, the UCLA Department of Medicine, the
Kyungpook National University Hospital,
the Beijing Cancer Hospital and the University of Oxford. For
more information on Celsion, visit our website:
http://www.celsion.com.
Celsion Investor Contact
Jeffrey W. Church
Sr. Vice President and CFO
609-482-2455
jchurch@celsion.com
SOURCE Celsion Corporation